Internal Medicine, Endocrinology, Diabetes, & Metabolism · San Juan, PR
NPI
1619143542
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
525 Ave Fd Roosevelt, La Torre de Plaza Ste 711
San Juan, PR, 00918
Phone (787) 764-8880
Groups this clinician bills Medicare through
Medicare paid, 2024
$24K
308 services
Medicare patients, 2024
140
Average age 77
Drug cost, 2024
$2.1M
5,514 prescriptions
Company payments, 2025
$4,035
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Meliza Martinez Rodriguez was code 99214 (office e&m - established), 180 times for 103 patients. In total Meliza Martinez Rodriguez billed 308 services in 11 codes, and Medicare paid $24K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-05-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 180 | 103 | $88.57 | $16K |
| 99213 Office E&M - Established | Office | 65 | 45 | $62.51 | $4,063 |
| 95251 Test - Miscellaneous | Office | 18 | 14 | $25.39 | $457 |
| 95250 Test - Miscellaneous | Office | 16 | 15 | $99.46 | $1,591 |
By year: 2022 $30K for 352 services; 2023 $25K for 308 services; 2024 $24K for 308 services.
Medicare prescription drug claims, 2024
In 2024, the drug Meliza Martinez Rodriguez prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 433 prescriptions and refills. In total Meliza Martinez Rodriguez wrote 5,514 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 433 | 1,078 | 167 | $46K |
| Trulicity Dulaglutide | 312 | 444 | 77 | $441K |
| Rosuvastatin Calcium Generic | 220 | 589 | 100 | $4,692 |
| Janumet Xr Sitagliptin Phos/Metformin Hcl | 189 | 360 | 66 | $188K |
| Mounjaro Tirzepatide | 187 | 224 | 46 | $242K |
| Atorvastatin Calcium Generic | 174 | 463 | 93 | $2,366 |
| Ozempic Semaglutide | 162 | 223 | 46 | $196K |
| Gabapentin Generic | 159 | 367 | 70 | $2,914 |
| Losartan Potassium Generic | 134 | 358 | 72 | $1,677 |
| Metoprolol Succinate Generic | 113 | 301 | 53 | $2,921 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 107 | 227 | 54 | $17K |
| Amlodipine Besylate Generic | 99 | 250 | 46 | $892 |
| Sertraline Hcl Generic | 83 | 213 | 44 | $1,146 |
| Janumet Sitagliptin Phos/Metformin Hcl | 80 | 144 | 35 | $74K |
| Famotidine Generic | 78 | 178 | 39 | $903 |
Brand drugs: 2,385 claims; generic drugs: 3,021 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Meliza Martinez Rodriguez $4,035 ($4,035 in general payments such as food, travel and fees) from 10 companies. The largest payer was Amgen Inc. with $3,422.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 13 | $3,422 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $146 |
| Abbott Laboratories ABT | 5 | $110 |
| Eli Lilly Export S.A. Puerto Rico Branch LLY | 3 | $75 |
| Novo Nordisk Inc NVO | 3 | $72.81 |
| Bayer Puerto Rico Inc. BAYN.DE | 3 | $60.17 |
| Abbvie Inc. ABBV | 2 | $52.08 |
| Dexcom, Inc. DXCM | 2 | $40 |
| Pbg Puerto Rico LLC | 2 | $38.87 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $18.73 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.